UNSPSC 51123205: Pentisomide

This classification denotes an antiarrhythmic agent with the molecular formula C19H33N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 506T8KTW5Q, chemically known as 2-pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-(2-methylpropyl)-, (+-)- but more generally known as pentisomide, which bears US NIH Compound Identifier 65847. European Medicines Agency schedules Pentisomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09697MIG.

UNSPSC 51123205 Pentisomide, a Commodity code, captures pharmaceutical procurement by state and local government agencies for emergency medical services, health and human services programs, and cooperative purchasing initiatives. State and local governments buy specific medications under this code—including injectable vasopressors, cardiac medications, and other critical-care drugs—through sealed competitive bids, requests for proposals, and cooperative purchasing agreements. Issuing bodies span city fire rescue departments, state health and human services agencies, and multistate cooperative purchasing alliances administering contracts on behalf of dozens of member jurisdictions. Scope typically includes supply of branded or generic medications with strict expiration-date requirements (often nine months or more from acceptance), adherence to FDA and cGMP standards, OSHA Safety Data Sheets, warranty for defect-free materials, and expedited delivery windows. Contracts commonly run one to three years with optional renewals and may include sheltered-market set-asides for small local business enterprises.

Recent activity clusters in Florida and the Upper Midwest with national reach through cooperative agreements. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (Labetalol, Epinephrine, Adenosine, and Diltiazem vials for Tampa Fire Rescue) with a due date of April 8, 2026, and estimated contract value of $40,000, featuring a 5 percent bid discount for Small Local Business Enterprise participation. The Minnesota Multistate Cooperative Purchasing Alliance (administered by Minnesota Department of Administration) issued RFP S1070000015802 for Generic Multi Source Pharmaceuticals and OTC Products, due March 26, 2026, requiring distribution through three authorized wholesalers (Cencora, Cardinal Health 110 and 112, Morris & Dickson) and serving Oregon and multiple state and local member facilities. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 to gather market intelligence on direct-to-manufacturer prescription programs. Opportunities emphasize competitive pricing, regulatory compliance documentation, and established relationships with authorized pharmaceutical wholesalers and group purchasing organizations.